首頁 > 市場調查報告書 > 醫療設備

病患監測血糖監測

血糖監測市場：按類型、按組成部分、按地區 - 規模、份額、展望、機會分析，2022-2028 年

市場調查報告書

商品編碼

1181706

血糖監測市場：按類型、按組成部分、按地區 - 規模、份額、展望、機會分析，2022-2028 年

Blood Glucose Monitoring Market, By Type, By Component, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年12月05日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

定期監測血糖對於糖尿病管理至關重要。這是糖尿病患者為控制 1 型或 2 型糖尿病所能做的最重要的事情。血糖監測是使用血糖儀檢測血液中的葡萄糖水平。自我監測血糖儀 (SMBG) 是一種手持設備，供患者在家中檢查血糖水平。另一方面，連續血糖儀 (CGM) 可以通過更少的手指測試幫助管理 1 型或 2 型糖尿病。因此，隨著糖尿病患者數量的增加，對血糖監測的需求也在迅速增加。

市場動態

糖尿病患病率或發病率上升、公眾對糖尿病管理的認識提高、血糖監測設備的採用率增加、研發增加、市場上產品數量增加、有利的政府舉措是預計推動增長的主要因素全球血糖監測市場。

例如，2021 年 3 月，羅氏宣布推出新的聯網血糖監測系統 ACCU-CHEK Instant System，該系統支持並使羅氏的綜合個性化糖尿病管理 (iPDM) 方法得以增加。該系統通過藍牙連接連接到 mySugr 應用程序，並可以將血糖讀數無線傳輸到 mySugr 應用程序。該應用程序提供糖尿病管理功能，例如 mySugr 胰島素計算器，以及快速了解用戶的糖尿病數據。

此外，2019 年 1 月，美國食品和藥物管理局 (FDA) 批准了一種用於 1 型和 2 型糖尿病患者的植入式連續血糖監測 (CGM) 設備。該設備稱為 Eversense 連續血糖監測系統，可提供長達三個月的監測，並被批准用於 18 歲及以上的人群。

這項研究的主要特點

本報告對全球血糖監測市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR %) 增長情況。
解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
它根據以下參數介紹了全球血糖監測市場的主要參與者，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
本研究涵蓋的主要公司包括 Sensonics、Acon Laboratories Inc.、Bionime Corporation、AgaMatrix Inc.、Ascensia Diabetes Care、ARKRAY Inc.、Medisana AG、Medtronic PLC、DexCom Inc.、LifeScan Inc.、Roche Diagnostics 、Abbott Diabetes Care、Trivida Functional Medicine 和 Rossmax International Ltd. 等。
這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
《全球血糖監測市場》報告針對行業內的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球血糖監測市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第二章市場展望

報告內容
- 市場定義和範圍
執行摘要
- 市場概況：按類型分類
- 市場概況：按組件分類
- 市場概況：按地區
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 全球糖尿病患病率和發病率增加
- 血糖儀成本高，報銷率低
- 血糖儀普及率提高
影響分析
主要亮點
監管場景
產品發布和批准
害蟲分析
對 PORTER 的分析
合併/收購場景

第 4 章全球血糖監測市場 - 冠狀病毒 (COVID-19) 大流行的影響

COVID-19 的流行病學
供應方和需求方分析
經濟影響

第 5 章全球血糖監測市場，按類型，2017-2028

自我監測血糖儀
連續血糖監測設備

第 6 章全球血糖監測市場的組成部分，2017-2028

血糖儀設備
試紙
柳葉刀
傳感器
耐用性

第 7 章全球血糖監測市場，按地區劃分，2017-2028

北美
歐洲
亞太地區
拉丁美洲
中東和非洲
世界其他地方

第八章競爭格局

Senseonics
Medisana AG
Acon Laboratories Inc.
Bionime Corporation
AgaMatrix Inc.
Ascensia Diabetes Care
ARKRAY Inc.
Medtronic PLC
DexCom Inc.
LifeScan Inc.
Roche Diagnostics
Abbott Diabetes Care
Trivida Functional Medicine
Rossmax International Ltd.

第 9 章

調查方法
關於出版商

簡介目錄

Product Code: CMI5382

Regular blood glucose monitoring is essential for diabetes management. It is the most important thing people with diabetes can do to manage Type 1 or Type 2 diabetes. Blood glucose monitoring is the use of a glucose meter to test the concentration of glucose in the blood. Self-monitoring of blood glucose (SMBG) devices are handheld devices used by patients at home to check their blood glucose levels. While, continuous glucose monitoring (CGM) devices help people manage Type 1 or Type 2 diabetes with fewer fingerstick tests. Thus, with the increase in prevalence of diabetes, the demand for blood glucose monitoring is also increasing rapidly.

Market Dynamics:

Rise in prevalence or incidence of diabetes, increase in awareness among people about diabetes management, increase in adoption of blood glucose monitoring devices, increase in research and development, increase in number of product launches, and favorable government initiatives are major factors expected to drive growth of the global blood glucose monitoring market.

For instance, in March 2021, Roche announced the launch of the new Accu-Chek Instant system, a new connected blood glucose monitoring system, which supports and enables Roche's approach of integrated Personalized Diabetes Management (iPDM). The system features Bluetooth enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app. The app offers users quick insights to their diabetes data in addition to diabetes management features like the mySugr insulin calculator.

Moreover, in January 2019, the U.S. Food and Drug Administration (FDA) approved implantable continuous glucose monitoring (CGM) device for individuals with type 1 and type 2 diabetes. The device, called the Eversense Continuous Glucose Monitoring System, provides monitoring for up to three months, and it's approved for people age 18 and older.

Key features of the study:

This report provides in-depth analysis of the global blood glucose monitoring market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global blood glucose monitoring market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Senseonics, Acon Laboratories Inc., Bionime Corporation, AgaMatrix Inc., Ascensia Diabetes Care, ARKRAY Inc., Medisana AG, Medtronic PLC, DexCom Inc., LifeScan Inc., Roche Diagnostics, Abbott Diabetes Care, Trivida Functional Medicine, and Rossmax International Ltd., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global blood glucose monitoring market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose monitoring market.

Detailed Segmentation:

Global Blood Glucose Monitoring Market, By Type:
- Self-monitoring blood glucose devices
- Continuous glucose monitoring devices
Global Blood Glucose Monitoring Market, By Component:
- Glucometer devices
- Test strips
- Lancets
- Sensors
- Durables
Global Blood Glucose Monitoring Market, By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Company Profiles:
- Senseonics
- Medisana AG
- Acon Laboratories Inc.
- Bionime Corporation
- AgaMatrix Inc.
- Ascensia Diabetes Care
- ARKRAY Inc.
- Medtronic PLC
- DexCom Inc.
- LifeScan Inc.
- Roche Diagnostics
- Abbott Diabetes Care
- Trivida Functional Medicine
- Rossmax International Ltd.

Market Dynamics
- Increase in prevalence/incidence of diabetes across the globe
- High cost and poor reimbursement of blood glucose monitoring devices
- Increase in adoption of blood glucose monitoring devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Blood Glucose Monitoring Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Blood Glucose Monitoring Market, By Type, 2017-2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Self-monitoring blood glucose devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Continuous glucose monitoring devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Blood Glucose Monitoring Market, By Component, 2017-2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Glucometer devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Test strips
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Lancets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Sensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Durables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Blood Glucose Monitoring Market, By Geography, 2017-2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

Senseonics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medisana AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Acon Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bionime Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AgaMatrix Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ascensia Diabetes Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ARKRAY Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DexCom Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LifeScan Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Diabetes Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Trivida Functional Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Rossmax International Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views